与抗生素耐药性相关的突变：是时候验证测序观察结果了。
Mutations Associated to Antibiotic-Resistant : It Is Time to Validate Sequencing Observations.
作者信息
Pichon Maxime, Luzarraga Victor, Burucoa Christophe
机构信息
CHU Poitiers, Bacteriology Laboratory, Infectious Agents Department, 86021 Poitiers, France.
Pharmacology of Antimicrobial Agents and Antibiotic Resistance, University of Poitiers, INSERM U1070, 86034 Poitiers, France.
出版信息
J Clin Med. 2022 Jul 24;11(15):4293. doi: 10.3390/jcm11154293.
Abstract
, a Gram-negative microaerophilic microorganism, is the only bacterial pathogen classified as a Class I carcinogen [...].
摘要
幽门螺杆菌，一种革兰氏阴性微需氧微生物，是唯一被列为一类致癌物的细菌病原体[……] 。 （注：原文中未给出具体的主语，根据语境推测这里应该是指“Helicobacter pylori”，即幽门螺杆菌，翻译时补充完整了主语）
相似文献
1
Mutations Associated to Antibiotic-Resistant : It Is Time to Validate Sequencing Observations.与抗生素耐药性相关的突变：是时候验证测序观察结果了。
J Clin Med. 2022 Jul 24;11(15):4293. doi: 10.3390/jcm11154293.
2
Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.幽门螺杆菌在抗生素时代后的治疗——寻找新的药物靶点。
Appl Microbiol Biotechnol. 2020 Dec;104(23):9891-9905. doi: 10.1007/s00253-020-10945-w. Epub 2020 Oct 14.
3
Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms.遗传宿主因素在幽门螺杆菌诱导的致癌作用中的作用：新兴的新范例。
Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):42-52. doi: 10.1016/j.bbcan.2017.11.003. Epub 2017 Nov 24.
4
Antibacterial action of acriflavine hydrochloride for eradication of the gastric pathogen Helicobacter pylori.盐酸吖啶黄对根除胃病原体幽门螺杆菌的抗菌作用。
FEMS Microbiol Lett. 2020 Nov 23;367(21). doi: 10.1093/femsle/fnaa178.
5
Helicobacter pylori cultivation from gastric biopsies and susceptibility to antibiotics used in empirical therapy.从胃活检组织中培养幽门螺杆菌以及对经验性治疗中使用的抗生素的敏感性。
Roum Arch Microbiol Immunol. 2011 Apr-Jun;70(2):60-4.
6
CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant Strain of Helicobacter pylori Infection.CYP2C19基因分型、CagA基因分型与幽门螺杆菌感染的抗生素耐药菌株
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1243-1247. doi: 10.31557/APJCP.2019.20.4.1243.
7
Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.粪便标本检测克拉霉素耐药幽门螺杆菌在接受根除治疗的年轻成年人中的应用。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12396. Epub 2017 May 22.
8
Clinical Relevance of Infection.感染的临床相关性
J Clin Med. 2021 Aug 6;10(16):3473. doi: 10.3390/jcm10163473.
9
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.幽门螺杆菌基因型和抗生素耐药模式与人及狗相关，与克拉霉素耐药的 A2142G 和 A2143G 点突变有关。
Microb Pathog. 2018 Oct;123:330-338. doi: 10.1016/j.micpath.2018.07.016. Epub 2018 Jul 18.
10
Antibiotic treatment for Helicobacter pylori: Is the end coming?幽门螺杆菌的抗生素治疗：终点将至？
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):183-98. doi: 10.4292/wjgpt.v6.i4.183.
引用本文的文献
1
Identification of genetic determinants of antibiotic resistance in Helicobacter pylori isolates in Vietnam by high-throughput sequencing.通过高通量测序鉴定越南幽门螺杆菌分离株中抗生素耐药性的遗传决定因素。
BMC Microbiol. 2025 May 2;25(1):264. doi: 10.1186/s12866-025-03990-w.
2
Whole Genome Sequencing for Studying Antimicrobial Resistance.用于研究抗菌素耐药性的全基因组测序
Antibiotics (Basel). 2023 Jun 30;12(7):1135. doi: 10.3390/antibiotics12071135.
3
Polymorphism in autophagy-related genes LRP1 and CAPZA1 may promote gastric mucosal atrophy.自噬相关基因LRP1和CAPZA1的多态性可能促进胃黏膜萎缩。
Genes Environ. 2023 May 17;45(1):18. doi: 10.1186/s41021-023-00274-5.
4
How Did We End Up Using a Quadruple Guided Therapy Combining At Least Two Antibiotics with a PPI to Eradicate ?我们最终是如何采用一种将至少两种抗生素与质子泵抑制剂联合使用的四联疗法来根除（幽门螺杆菌）的呢？
J Clin Med. 2022 Sep 3;11(17):5216. doi: 10.3390/jcm11175216.
本文引用的文献
1
Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Next Generation Sequencing Data.基于下一代测序数据的生物标志物特征分析及毒力和抗生素耐药性预测。
Biomolecules. 2022 May 11;12(5):691. doi: 10.3390/biom12050691.
2
Geospatial analysis of Helicobacter pylori infection in South Australia: Should location influence eradication therapy?澳大利亚南部幽门螺杆菌感染的地理空间分析：地理位置是否会影响根除治疗？
J Gastroenterol Hepatol. 2022 Jul;37(7):1263-1274. doi: 10.1111/jgh.15832. Epub 2022 Mar 31.
3
New Strategy for the Detection and Treatment of Infections in Primary Care Guided by a Non-Invasive PCR in Stool: Protocol of the French HepyPrim Study.基于粪便非侵入性PCR检测的基层医疗中感染性疾病诊治新策略：法国HepyPrim研究方案
J Clin Med. 2022 Feb 22;11(5):1151. doi: 10.3390/jcm11051151.
4
Where to Biopsy to Detect and How Many Biopsies Are Needed to Detect Antibiotic Resistance in a Human Stomach.在人体胃部何处进行活检以检测以及需要进行多少次活检才能检测出抗生素耐药性
J Clin Med. 2020 Aug 31;9(9):2812. doi: 10.3390/jcm9092812.
5
Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay.使用Amplidiag幽门螺杆菌+克拉霉素实时PCR检测法对粪便中幽门螺杆菌及克拉霉素耐药性进行非侵入性检测的诊断准确性
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01787-19.
6
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.幽门螺杆菌抗生素耐药性的流行情况：世界卫生组织区域的系统评价和荟萃分析。
Gastroenterology. 2018 Nov;155(5):1372-1382.e17. doi: 10.1053/j.gastro.2018.07.007. Epub 2018 Jul 7.
7
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.全球幽门螺杆菌感染率：系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27.
8
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
9
T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori.T2182C突变与幽门螺杆菌对克拉霉素的耐药性无关。
Antimicrob Agents Chemother. 2005 Feb;49(2):868; author reply 868-70. doi: 10.1128/AAC.49.2.868-870.2005.
10
Helicobacter pylori infection.幽门螺杆菌感染
N Engl J Med. 2002 Oct 10;347(15):1175-86. doi: 10.1056/NEJMra020542.
Zotero 插件